Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
固定剂量抗PD-1抗体SHR-1210在晚期实体瘤中的安全性、抗肿瘤活性和药代动力学：一项剂量递增的1期研究
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-018-0100-3
Mo, Hongnan; Huang, Jing; Xu, Jiachen; Chen, Xuelian; Wu, Dawei; Qu, Dong; Wang, Xi; Lan, Bo; Wang, Xingyuan; Xu, Jianping; Zhang, Honggang; Chi, Yihebali; Yang, Qing; Xu, Binghe
